Clinical trial
A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.
NCT00203723 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- May 31, 2006
- Enrollment
- 45
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depression